Current approaches to osteoporosis treatment
Sian Yik Lim1, Marcy B Bolster
1Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Recent advances in osteoporosis treatment offer new therapeutic options for fracture risk reduction. Rheumatologists should be aware of these evolving strategies, including individualized and combination therapies, and potential safety concerns.
Area of Science:
- Orthopedics
- Rheumatology
- Pharmacology
Background:
- Osteoporosis is a skeletal disorder characterized by reduced bone strength and increased fracture risk.
- Advances in bone biology have driven significant therapeutic progress in osteoporosis management.
Purpose of the Study:
- To review current osteoporosis treatment approaches.
- To highlight issues relevant to practicing rheumatologists in managing osteoporosis.
Main Methods:
- Review of recent therapeutic advances in osteoporosis.
- Analysis of new agents and treatment strategies.
- Consideration of safety surveillance data.
Main Results:
- New agents like denosumab, teriparatide, selective estrogen-receptor modulators, romosozumab, and odanacatib have emerged.
- Treatment individualization, combination therapy, and goal-based approaches are now possible.
- Bisphosphonate use is associated with risks like osteonecrosis of the jaw and atypical femoral fractures, necessitating drug holidays.
Conclusions:
- Significant progress has been made in understanding and managing osteoporosis.
- Rheumatologists must stay informed about current osteoporosis management strategies due to their frequent encounter with bone-loss-related conditions.
More Related Videos
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling and Repair
